Pacific Biosciences of California, Inc.

$32.45 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Join the waitlist

About Pacific Biosciences of California, Inc.

Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. The Company is engaged in the development, manufacturing and marketing of an integrated platform for genetic analysis. Its Single Molecule, Real-Time (SMRT) technology enables single molecule, real-time detection of biological processes. It offers The SMRT Cell, Phospholinked nucleotides and The PacBio RS II and Sequel instruments. Its SMRT technology enables the observation of deoxyribonucleic acid (DNA) synthesis as it occurs in real-time by harnessing the natural process of DNA replication, which is actuated by the DNA polymerase. Its phospholinked nucleotides have a fluorescent dye attached to the phosphate chain of the nucleotide rather than to the base. The PacBio RS II and Sequel instruments include optics, automated liquid handling, a touchscreen control interface and computational hardware and software.

Stock Analysis

last close $33.49
1-mo return 22.4%
3-mo return -8.7%
avg daily vol. 3.37M
52-week high 53.69
52-week low 2.66
market cap. $6.5B
forward pe -
annual div. -
roe 15.1%
ltg forecast -
dividend yield -
annual rev. $79M
inst own. 99.3%
baraka

Join the waitlist for early access and a chance to earn $50 in free stock

Join the waitlist